Rectum dose reduction and individual treatment plan optimization for high-dose-rate prostate brachytherapy

Brachytherapy

Volumn 6, Issue 4, 2007, Pages 280-285

  Bölling, Tobias ^a   Moustakis, Christos ^a   Elsayed, Hassan ^a   Müller, Stefan Bodo ^a   Weining, Christoph ^a   Reinartz, Gabriele ^a   Ernst, Iris ^a   Willich, Normann ^a   Könemann, Stefan ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

High dose rate brachytherapy; Prostate; Rectum position; Treatment plan optimization

Indexed keywords

IRIDIUM 192;

ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RADIATION DOSE; RECTUM; TREATMENT PLANNING; ULTRASOUND; URETHRA;

BRACHYTHERAPY; COMBINED MODALITY THERAPY; HUMANS; IRIDIUM RADIOISOTOPES; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RECTUM; URETHRA;

EID: 35649027265     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2007.06.001     Document Type: Article

References (21)

1. Zelefsky M.J., Valicenti R.K., Goodman K., et al. Prostate cancer. In: Perez C.A., Brady L.W., Halperin E.C., et al. (Eds). Principles and practice of radiation oncology. 4th ed. (2004), Lippincott Williams & Wilkins, Philadelphia, PA 1730-1733
2. Pinkawa M., Fischedick K., Treusacher P., et al. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer-a phase II study. Radiother Oncol 78 (2006) 41-46
3. Critz F.A., Levinson K., Williams W.H., et al. Prostate-specific antigen nadir of 0.5 ng/ml or less defines disease freedom for surgically staged men irradiated for prostate cancer. Urology 49 (1997) 668-672
4. Galalae R.M., Kovacs G., Schultze J., et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 81-90
5. Kovacs G., Galalae R., Loch T., et al. Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer. Strahlenther Onkol 175 Suppl. 2 (1999) 87-88
6. Mate T.P., Gottesman J.E., Hatton J., et al. High dose-rate afterloading 192iridium prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 41 (1998) 525-533
7. Yamada Y., Bhatia S., Zaider M., et al. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 5 (2006) 157-164
8. Hsu I.C., Cabrera A.R., Weinberg V., et al. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy 4 (2005) 202-206
9. Mahmoudieh A., Tremblay C., Beaulieu C., et al. Anatomy-based inverse planning dose optimization in HDR prostate implant: A toxicity study. Radiother Oncol 75 (2005) 318-324
10. Ghilezan M., Kestin L., Gustafson G., et al. A comprehensive toxicity analysis of 1232 prostate cancer patients treated with pelvic external beam radiotherapy (EBRT) with high dose rate (HDR) brachytherapy boost, adaptive EBRT (ART), or brachytherapy alone (BT). Int J Radiat Oncol Biol Phys 66 3, Suppl. (2006) S60
11. Farrus B., Pons F., Sanchez-Reyes A., et al. Quality assurance of interstitial brachytherapy technique in lip cancer: Comparison of actual performance with the Paris System recommendations. Radiother Oncol 38 (1996) 145-151
12. Gillin M.T., Dunning B.F., Lawton C.A., et al. Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol. Brachytherapy 5 (2006) 152-156
13. Kovács G., Pötter R., Loch T., et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 74 (2005) 137-148
14. ICRU 50. Prescribing, recording and reporting photon beam therapy (1993), ICRU, Bethesda, MD
15. Hille A., Schmidberger H., Töws N., et al. The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer. A prospective three-dimensional analysis. Strahlenther Onkol 181 (2005) 709-716
16. Gerstner N., Wachter S., Dorner D., et al. Significance of a rectal balloon as internal immobilization device in conformal radiotherapy of prostatic carcinoma. Strahlenther Onkol 175 (1999) 232-238
17. Brossner C., Winterholer A., Roehlich M., et al. Distribution of prostate carcinoma foci within the peripheral zone: Analysis of 8,062 prostate biopsy cores. World J Urol 21 (2003) 163-166
18. Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44 (1999) 789-799
19. Fiorino C., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 953-962
20. Hartford A.C., Niemierko A., Adams J.A., et al. Conformal irradiation of the prostate: Estimating long-term rectal bleeding risk using dose-volume histograms. Int J Radiat Oncol Biol Phys 36 (1996) 721-730
21. Stasi M., Munoz F., Fiorino C., et al. Emptying the rectum before treatment delivery limits the variation of rectal dose-volume parameters during 3DCRT of prostate cancer. Radiother Oncol 80 (2006) 363-370